Optic atrophy
diseaseOn this page
Also known as atrophy of optic disk
Summary
Optic atrophy (MONDO:0003608) is a disease caused by variants in OPA1 and TMEM126A, with 75 cohort genes (6 GWAS associations across 7 studies) and 10 clinical trials. The dominant Reactome pathway is Cilium Assembly (12 cohort genes). Top therapeutic interventions include deferiprone and sitagliptin.
At a glance
- Causal genes: OPA1 (GenCC Definitive), TMEM126A (GenCC Definitive)
- Cohort genes: 75
- GWAS associations: 6
- ClinVar variants: 476
- Clinical trials: 10
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | optic atrophy |
| Mondo ID | MONDO:0003608 |
| MeSH | D009896 |
| DOID | DOID:5723 |
| ICD-10-CM | H47.2 |
| ICD-11 | 568505454 |
| NCIT | C34863 |
| SNOMED CT | 76976005 |
| UMLS | C0029124 |
| MedGen | 18180 |
| Is cancer (heuristic) | no |
Also known as: atrophy of optic disk
Data availability: 476 ClinVar variants · 6 GWAS associations (7 studies) · 3 GenCC gene-disease records.
Disease family
An umbrella term covering 3 Mondo subtypes.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › optic nerve disorder › optic atrophy
Related subtypes (7): optic disk drusen, optic nerve neoplasm, optic neuritis, anterior ischemic optic neuropathy, low tension glaucoma, extensive peripapillary myelinated nerve fibers, isolated optic nerve aplasia
Subtypes (3): glaucomatous atrophy of optic disk, primary optic atrophy, partial optic atrophy
Genetics & variants
GWAS landscape
6 GWAS associations across 7 studies. Top hits map to 2 distinct genes (as reported by GWAS).
Top associations by p-value
| rsID | p-value | Gene | Risk allele | Odds ratio |
|---|---|---|---|---|
| rs144654840 | 3e-11 | IRX1 - LINC02063 | T | 1.75 |
| rs746386 | 1e-09 | SERPINA12 - SERPINA4 | ? | |
| rs75720470 | 9e-08 | LYPD6B | T | 0.67 |
| rs76914338 | 4e-07 | NEK7 - ATP6V1G3 | G | 0.54 |
| rs546337899 | 4e-07 | TMPRSS2 | G | 0.94 |
| rs12405441 | 8e-07 | LINC02781 - LINC02782 | T | 0.49 |
Top studies (by case count)
| Study | Lead author | Year | Cases | Controls | Title |
|---|---|---|---|---|---|
| GCST90477763 | Verma A | 2024 | 4,922 | 440,844 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90477762 | Verma A | 2024 | 2,374 | 117,039 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90480094 | Verma A | 2024 | 2,374 | 117,039 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90477761 | Verma A | 2024 | 535 | 58,733 | Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. |
| GCST90651304 | Liu TY | 2025 | 69 | 56,493 | Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population. |
| GCST90436016 | Zhou W | 2018 | 58 | 401,245 | Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. |
| GCST90104240 | Choe EK | 2022 | 0 | 0 | Leveraging deep phenotyping from health check-up cohort with 10,000 Korean individuals for phenome-wide association study of 136 traits. |
Variant details and genetic-evidence tiers
Tier distribution (top 50 variants)
| Tier | Variants |
|---|---|
| Tier 1: coding | 0 |
| Tier 2: splice/UTR | 0 |
| Tier 3: regulatory | 0 |
| Tier 4: intronic/intergenic | 6 |
MAF distribution
| Bucket | Variants |
|---|---|
| common (>=0.05) | 3 |
| low_freq (0.01-0.05) | 2 |
| rare (<0.01) | 1 |
| unknown | 0 |
Functional consequences
| Consequence | Count |
|---|---|
| intergenic_variant | 3 |
| intron_variant | 3 |
Top variants
| rsID | Chr | Pos | Alleles | MAF | Consequence | Gene | p-value | Tier |
|---|---|---|---|---|---|---|---|---|
| rs144654840 | 5 | 3938655 | T>A | 0.001 | intergenic_variant | IRX1 - LINC02063 | 3e-11 | Tier 4: intronic/intergenic |
| rs746386 | 14 | 94540589 | T>C | 0.05 | intergenic_variant | SERPINA12 - SERPINA4 | 1e-09 | Tier 4: intronic/intergenic |
| rs75720470 | 2 | 149056403 | G>T | 0.046 | intron_variant | LYPD6B | 9e-08 | Tier 4: intronic/intergenic |
| rs76914338 | 1 | 198443151 | A>G | 0.073 | intron_variant | NEK7 - ATP6V1G3 | 4e-07 | Tier 4: intronic/intergenic |
| rs546337899 | 21 | 41502680 | T>C,G | 0.015 | intron_variant | TMPRSS2 | 4e-07 | Tier 4: intronic/intergenic |
| rs12405441 | 1 | 5027090 | C>T | 0.09 | intergenic_variant | LINC02781 - LINC02782 | 8e-07 | Tier 4: intronic/intergenic |
ClinVar germline variants
476 retrieved; paginated sample, class counts are floors:
208 uncertain significance, 93 pathogenic, 91 conflicting classifications of pathogenicity, 34 pathogenic/likely pathogenic, 32 likely pathogenic, 8 likely benign, 8 benign, 2 benign/likely benign
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 973107 | NM_006796.3(AFG3L2):c.[1385C>T;1858C>A] | Pathogenic | no assertion criteria provided | |
| 973111 | NM_006796.3(AFG3L2):c.[1901_1902del;916A>G] | Pathogenic | no assertion criteria provided | |
| 973112 | NM_006796.3(AFG3L2):c.[1814A>G;2375dup] | Pathogenic | no assertion criteria provided | |
| 236095 | NM_000350.3(ABCA4):c.2875A>G (p.Thr959Ala) | ABCA4 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 7894 | NM_000350.3(ABCA4):c.3113C>T (p.Ala1038Val) | ABCA4 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 99403 | NM_000350.3(ABCA4):c.5714+5G>A | ABCA4 | Pathogenic | reviewed by expert panel |
| 433266 | NM_001171.6(ABCC6):c.2252T>A (p.Met751Lys) | ABCC6 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 189314 | NM_001098.3(ACO2):c.2328_2331del (p.Lys776fs) | ACO2 | Pathogenic | criteria provided, single submitter |
| 3250075 | NM_001098.3(ACO2):c.1371-1G>C | ACO2 | Pathogenic | no assertion criteria provided |
| 3250099 | NM_001098.3(ACO2):c.1360C>T (p.Gln454Ter) | ACO2 | Pathogenic | no assertion criteria provided |
| 523244 | GRCh37/hg19 1q21.1-21.2(chr1:146618988-147824207) | ACP6 | Pathogenic | criteria provided, single submitter |
| 565275 | NM_006796.3(AFG3L2):c.1402C>T (p.Arg468Cys) | AFG3L2 | Pathogenic | criteria provided, single submitter |
| 973104 | NM_006796.3(AFG3L2):c.1394G>A (p.Arg465Lys) | AFG3L2 | Pathogenic | no assertion criteria provided |
| 973106 | NM_006796.3(AFG3L2):c.1541C>T (p.Pro514Leu) | AFG3L2 | Pathogenic | no assertion criteria provided |
| 973108 | NM_006796.3(AFG3L2):c.1289C>T (p.Thr430Ile) | AFG3L2 | Pathogenic | no assertion criteria provided |
| 973109 | NM_006796.3(AFG3L2):c.1036C>T (p.Leu346Phe) | AFG3L2 | Pathogenic | no assertion criteria provided |
| 162088 | NM_176824.3(BBS7):c.1967_1968delinsC (p.Leu656fs) | BBS7 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 587382 | NM_001256789.3(CACNA1F):c.4471C>T (p.Arg1491Ter) | CACNA1F | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 812245 | NM_001256789.3(CACNA1F):c.4051C>T (p.Arg1351Ter) | CACNA1F | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 9481 | NM_001298.3(CNGA3):c.829C>T (p.Arg277Cys) | CNGA3 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 5225 | NM_019098.5(CNGB3):c.1148del (p.Thr383fs) | CNGB3 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 3250016 | NM_207352.4(CYP4V2):c.1090+1G>C | CYP4V2 | Pathogenic | no assertion criteria provided |
| 976691 | NM_032317.3(DNAJC30):c.152A>G (p.Tyr51Cys) | DNAJC30 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 31204 | NM_001004334.4(GPR179):c.984del (p.Ser329fs) | GPR179 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 808255 | NM_001004334.4(GPR179):c.1573C>T (p.Arg525Ter) | GPR179 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 98582 | NM_000180.4(GUCY2D):c.2944+1del | GUCY2D | Pathogenic | reviewed by expert panel |
| 183353 | NM_194279.4(ISCA2):c.229G>A (p.Gly77Ser) | ISCA2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 3250032 | NC_000003.12:g.(?193593498)(193694763_?)del | LOC126806913 | Pathogenic | criteria provided, single submitter |
| 95713 | NM_130837.3(OPA1):c.1834C>T (p.Arg612Ter) | LOC126806913 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 374878 | NM_016011.5(MECR):c.695G>A (p.Gly232Glu) | MECR | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 38 · Orphanet: 145 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| MED12 | Definitive | Autosomal dominant | autosomal dominant optic atrophy, classic form | 21 |
| OPA1 | Definitive | Autosomal dominant | autosomal dominant optic atrophy, classic form | 11 |
| TMEM126A | Definitive | Autosomal recessive | optic atrophy | 5 |
| NDUFA7 | Limited | Autosomal recessive | optic atrophy |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| MED12 | Orphanet:1415 | Hardikar syndrome |
| MED12 | Orphanet:293707 | Blepharophimosis-intellectual disability syndrome, MKB type |
| MED12 | Orphanet:776 | Lujan-Fryns syndrome |
| MED12 | Orphanet:777 | X-linked non-syndromic intellectual disability |
| MED12 | Orphanet:93932 | FG syndrome type 1 |
| TMEM126A | Orphanet:227976 | Autosomal recessive optic atrophy, OPA7 type |
| OPA1 | Orphanet:1215 | Autosomal dominant optic atrophy plus syndrome |
| OPA1 | Orphanet:1239 | Behr syndrome |
| OPA1 | Orphanet:98673 | Autosomal dominant optic atrophy, classic form |
| RGS9 | Orphanet:75374 | Bradyopsia |
| RHO | Orphanet:215 | Congenital stationary night blindness |
| RHO | Orphanet:52427 | Retinitis punctata albescens |
| RHO | Orphanet:791 | Retinitis pigmentosa |
| RLBP1 | Orphanet:227796 | Fundus albipunctatus |
| RLBP1 | Orphanet:52427 | Retinitis punctata albescens |
| RLBP1 | Orphanet:791 | Retinitis pigmentosa |
| RLBP1 | Orphanet:85128 | Bothnia retinal dystrophy |
| ROM1 | Orphanet:791 | Retinitis pigmentosa |
| RP9 | Orphanet:791 | Retinitis pigmentosa |
| RPGR | Orphanet:1872 | Cone rod dystrophy |
| RPGR | Orphanet:244 | Primary ciliary dyskinesia |
| RPGR | Orphanet:247522 | Primary ciliary dyskinesia-retinitis pigmentosa syndrome |
| RPGR | Orphanet:49382 | Achromatopsia |
| RPGR | Orphanet:791 | Retinitis pigmentosa |
| CWC27 | Orphanet:166035 | Brachydactyly-short stature-retinitis pigmentosa syndrome |
| SEMA4A | Orphanet:1872 | Cone rod dystrophy |
| SEMA4A | Orphanet:440437 | Familial colorectal cancer Type X |
| SEMA4A | Orphanet:791 | Retinitis pigmentosa |
| SEMA6B | Orphanet:178469 | Autosomal dominant non-syndromic intellectual disability |
| SNAP25 | Orphanet:98914 | Presynaptic congenital myasthenic syndromes |
| SPG7 | Orphanet:35689 | Primary lateral sclerosis |
| SPG7 | Orphanet:99013 | Spastic paraplegia type 7 |
| SSBP1 | Orphanet:90635 | Rare autosomal dominant non-syndromic sensorineural deafness type DFNA |
| PLK4 | Orphanet:2518 | Autosomal recessive chorioretinopathy-microcephaly syndrome |
| PLK4 | Orphanet:808 | Seckel syndrome |
| ACO2 | Orphanet:313850 | Infantile cerebellar-retinal degeneration |
| ACO2 | Orphanet:98676 | Autosomal recessive isolated optic atrophy |
| TTPA | Orphanet:96 | Ataxia with vitamin E deficiency |
| USH1C | Orphanet:231169 | Usher syndrome type 1 |
| USH1C | Orphanet:90636 | Rare autosomal recessive non-syndromic sensorineural deafness type DFNB |
| USH2A | Orphanet:231178 | Usher syndrome type 2 |
| USH2A | Orphanet:791 | Retinitis pigmentosa |
| CLRN1 | Orphanet:231183 | Usher syndrome type 3 |
| CLRN1 | Orphanet:791 | Retinitis pigmentosa |
| WFS1 | Orphanet:3463 | Wolfram syndrome |
| WFS1 | Orphanet:411590 | Wolfram-like syndrome |
| WFS1 | Orphanet:90635 | Rare autosomal dominant non-syndromic sensorineural deafness type DFNA |
| WFS1 | Orphanet:98991 | Early-onset nuclear cataract |
| SCAPER | Orphanet:110 | Bardet-Biedl syndrome |
| SCAPER | Orphanet:791 | Retinitis pigmentosa |
Cohort genes → proteins
75 cohort genes, 75 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 75 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| MED12 | HGNC:11957 | ENSG00000184634 | Q93074 | Mediator of RNA polymerase II transcription subunit 12 | gencc,clinvar |
| TMEM126A | HGNC:25382 | ENSG00000171202 | Q9H061 | Transmembrane protein 126A | gencc,clinvar |
| OPA1 | HGNC:8140 | ENSG00000198836 | O60313 | Dynamin-like GTPase OPA1, mitochondrial | gencc,clinvar |
| NDUFA7 | HGNC:7691 | ENSG00000267855 | O95182 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 | gencc |
| RGS9 | HGNC:10004 | ENSG00000108370 | O75916 | Regulator of G-protein signaling 9 | clinvar |
| RHO | HGNC:10012 | ENSG00000163914 | P08100 | Rhodopsin | clinvar |
| RLBP1 | HGNC:10024 | ENSG00000140522 | P12271 | Retinaldehyde-binding protein 1 | clinvar |
| ROM1 | HGNC:10254 | ENSG00000149489 | Q03395 | Rod outer segment membrane protein 1 | clinvar |
| RP9 | HGNC:10288 | ENSG00000164610 | Q8TA86 | Retinitis pigmentosa 9 protein | clinvar |
| RPGR | HGNC:10295 | ENSG00000156313 | Q92834 | X-linked retinitis pigmentosa GTPase regulator | clinvar |
| CWC27 | HGNC:10664 | ENSG00000153015 | Q6UX04 | Spliceosome-associated protein CWC27 homolog | clinvar |
| SEMA4A | HGNC:10729 | ENSG00000196189 | Q9H3S1 | Semaphorin-4A | clinvar |
| SEMA6B | HGNC:10739 | ENSG00000167680 | Q9H3T3 | Semaphorin-6B | clinvar |
| SLC24A1 | HGNC:10975 | ENSG00000074621 | O60721 | Sodium/potassium/calcium exchanger 1 | clinvar |
| SNAP25 | HGNC:11132 | ENSG00000132639 | P60880 | Synaptosomal-associated protein 25 | clinvar |
| SPG7 | HGNC:11237 | ENSG00000197912 | Q9UQ90 | Mitochondrial inner membrane m-AAA protease component paraplegin | clinvar |
| SSBP1 | HGNC:11317 | ENSG00000106028 | Q04837 | Single-stranded DNA-binding protein, mitochondrial | clinvar |
| PLK4 | HGNC:11397 | ENSG00000142731 | O00444 | Serine/threonine-protein kinase PLK4 | clinvar |
| ACO2 | HGNC:118 | ENSG00000100412 | Q99798 | Aconitate hydratase, mitochondrial | clinvar |
| TTPA | HGNC:12404 | ENSG00000137561 | P49638 | Alpha-tocopherol transfer protein | clinvar |
| USH1C | HGNC:12597 | ENSG00000006611 | Q9Y6N9 | Harmonin | clinvar |
| USH2A | HGNC:12601 | ENSG00000042781 | O75445 | Usherin | clinvar |
| CLRN1 | HGNC:12605 | ENSG00000163646 | P58418 | Clarin-1 | clinvar |
| WFS1 | HGNC:12762 | ENSG00000109501 | O76024 | Wolframin | clinvar |
| SCAPER | HGNC:13081 | ENSG00000140386 | Q9BY12 | S phase cyclin A-associated protein in the endoplasmic reticulum | clinvar |
| ARL6 | HGNC:13210 | ENSG00000113966 | Q9H0F7 | ADP-ribosylation factor-like protein 6 | clinvar |
| ESPN | HGNC:13281 | ENSG00000187017 | B1AK53 | Espin | clinvar |
| RPGRIP1 | HGNC:13436 | ENSG00000092200 | Q96KN7 | X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 | clinvar |
| ABITRAM | HGNC:1364 | ENSG00000119328 | Q9NX38 | Protein Abitram | clinvar |
| CDH23 | HGNC:13733 | ENSG00000107736 | Q9H251 | Cadherin-23 | clinvar |
| ADGRA3 | HGNC:13839 | ENSG00000152990 | Q8IWK6 | Adhesion G protein-coupled receptor A3 | clinvar |
| CABP4 | HGNC:1386 | ENSG00000175544 | P57796 | Calcium-binding protein 4 | clinvar |
| CACNA1F | HGNC:1393 | ENSG00000102001 | O60840 | Voltage-dependent L-type calcium channel subunit alpha-1F | clinvar |
| PIGQ | HGNC:14135 | ENSG00000007541 | Q9BRB3 | Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q | clinvar |
| C1QTNF5 | HGNC:14344 | ENSG00000223953 | Q9BXJ0 | Complement C1q tumor necrosis factor-related protein 5 | clinvar |
| ELOVL1 | HGNC:14418 | ENSG00000066322 | Q9BW60 | Very long chain fatty acid elongase 1 | clinvar |
| CDHR1 | HGNC:14550 | ENSG00000148600 | Q96JP9 | Cadherin-related family member 1 | clinvar |
| PCDH15 | HGNC:14674 | ENSG00000150275 | Q96QU1 | Protocadherin-15 | clinvar |
| GPHN | HGNC:15465 | ENSG00000171723 | Q9NQX3 | Gephyrin | clinvar |
| NBAS | HGNC:15625 | ENSG00000151779 | A2RRP1 | NBAS subunit of NRZ tethering complex | clinvar |
| ABHD12 | HGNC:15868 | ENSG00000100997 | Q8N2K0 | Lysophosphatidylserine lipase ABHD12 | clinvar |
| PANK2 | HGNC:15894 | ENSG00000125779 | Q9BZ23 | Pantothenate kinase 2, mitochondrial | clinvar |
| RP1L1 | HGNC:15946 | ENSG00000183638 | Q8IWN7 | Retinitis pigmentosa 1-like 1 protein | clinvar |
| PNPLA6 | HGNC:16268 | ENSG00000032444 | Q8IY17 | Patatin-like phospholipase domain-containing protein 6 | clinvar |
| USH1G | HGNC:16356 | ENSG00000182040 | Q495M9 | pre-mRNA splicing regulator USH1G | clinvar |
| WHRN | HGNC:16361 | ENSG00000095397 | Q9P202 | Whirlin | clinvar |
| DNAJC30 | HGNC:16410 | ENSG00000176410 | Q96LL9 | DnaJ homolog subfamily C member 30, mitochondrial | clinvar |
| TUBGCP4 | HGNC:16691 | ENSG00000137822 | Q9UGJ1 | Gamma-tubulin complex component 4 | clinvar |
| ZNF423 | HGNC:16762 | ENSG00000102935 | Q2M1K9 | Zinc finger protein 423 | clinvar |
| MFN2 | HGNC:16877 | ENSG00000116688 | O95140 | Mitofusin-2 | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| MED12 | Mediator of RNA polymerase II transcription subunit 12 | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. |
| TMEM126A | Transmembrane protein 126A | Protein required for the cotranslational protein quality control in the inner membrane of the mitochondria. |
| OPA1 | Dynamin-like GTPase OPA1, mitochondrial | Dynamin-related GTPase that is essential for normal mitochondrial morphology by mediating fusion of the mitochondrial inner membranes, regulating cristae morphology and maintaining respiratory chain function. |
| NDUFA7 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. |
| RGS9 | Regulator of G-protein signaling 9 | Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. |
| RHO | Rhodopsin | Photoreceptor required for image-forming vision at low light intensity. |
| RLBP1 | Retinaldehyde-binding protein 1 | Soluble retinoid carrier essential the proper function of both rod and cone photoreceptors. |
| ROM1 | Rod outer segment membrane protein 1 | Plays a role in rod outer segment (ROS) morphogenesis. |
| RP9 | Retinitis pigmentosa 9 protein | Is thought to be a target protein for the PIM1 kinase. |
| RPGR | X-linked retinitis pigmentosa GTPase regulator | Acts as a guanine-nucleotide releasing factor (GEF) for RAB8A and RAB37 by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP. |
| CWC27 | Spliceosome-associated protein CWC27 homolog | As part of the spliceosome, plays a role in pre-mRNA splicing. |
| SEMA4A | Semaphorin-4A | Cell surface receptor for PLXNB1, PLXNB2, PLXNB3 and PLXND1 that plays an important role in cell-cell signaling. |
| SEMA6B | Semaphorin-6B | Functions as a cell surface repellent for mossy fibers of developing neurons in the hippocampus where it plays a role in axon guidance. |
| SLC24A1 | Sodium/potassium/calcium exchanger 1 | Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) in exchange for 4 Na(+). |
| SNAP25 | Synaptosomal-associated protein 25 | t-SNARE involved in the molecular regulation of neurotransmitter release. |
| SPG7 | Mitochondrial inner membrane m-AAA protease component paraplegin | Catalytic component of the m-AAA protease, a protease that plays a key role in proteostasis of inner mitochondrial membrane proteins, and which is essential for axonal and neuron development. |
| SSBP1 | Single-stranded DNA-binding protein, mitochondrial | Binds preferentially and cooperatively to pyrimidine rich single-stranded DNA (ss-DNA). |
| PLK4 | Serine/threonine-protein kinase PLK4 | Serine/threonine-protein kinase that plays a central role in centriole duplication. |
| ACO2 | Aconitate hydratase, mitochondrial | Catalyzes the isomerization of citrate to isocitrate via cis-aconitate. |
| TTPA | Alpha-tocopherol transfer protein | Binds alpha-tocopherol, enhances its transfer between separate membranes, and stimulates its release from liver cells. |
| USH1C | Harmonin | Anchoring/scaffolding protein that is a part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. |
| USH2A | Usherin | Involved in hearing and vision as member of the USH2 complex. |
| CLRN1 | Clarin-1 | May have a role in the excitatory ribbon synapse junctions between hair cells and cochlear ganglion cells and presumably also in analogous synapses within the retina. |
| WFS1 | Wolframin | Participates in the regulation of cellular Ca(2+) homeostasis, at least partly, by modulating the filling state of the endoplasmic reticulum Ca(2+) store. |
| SCAPER | S phase cyclin A-associated protein in the endoplasmic reticulum | CCNA2/CDK2 regulatory protein that transiently maintains CCNA2 in the cytoplasm. |
| ARL6 | ADP-ribosylation factor-like protein 6 | Involved in membrane protein trafficking at the base of the ciliary organelle. |
| ESPN | Espin | Multifunctional actin-bundling protein. |
| RPGRIP1 | X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 | May function as scaffolding protein. |
| ABITRAM | Protein Abitram | Actin-binding protein that regulates actin polymerization, filopodia dynamics and increases the branching of proximal dendrites of developing neurons. |
| CDH23 | Cadherin-23 | Cadherins are calcium-dependent cell adhesion proteins. |
| ADGRA3 | Adhesion G protein-coupled receptor A3 | Orphan receptor that may have a role in planar cell polarity pathway. |
| CABP4 | Calcium-binding protein 4 | Involved in normal synaptic function through regulation of Ca(2+) influx and neurotransmitter release in photoreceptor synaptic terminals and in auditory transmission. |
| CACNA1F | Voltage-dependent L-type calcium channel subunit alpha-1F | Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene exp… |
| PIGQ | Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q | Part of the glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex that catalyzes the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine to phosphatidylinositol and participates in the first step of GPI bi… |
| ELOVL1 | Very long chain fatty acid elongase 1 | Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. |
| CDHR1 | Cadherin-related family member 1 | Potential calcium-dependent cell-adhesion protein. |
| PCDH15 | Protocadherin-15 | Calcium-dependent cell-adhesion protein. |
| GPHN | Gephyrin | Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. |
| NBAS | NBAS subunit of NRZ tethering complex | Involved in Golgi-to-endoplasmic reticulum (ER) retrograde transport; the function is proposed to depend on its association in the NRZ complex which is believed to play a role in SNARE assembly at the ER. |
| ABHD12 | Lysophosphatidylserine lipase ABHD12 | Lysophosphatidylserine (LPS) lipase that mediates the hydrolysis of lysophosphatidylserine, a class of signaling lipids that regulates immunological and neurological processes. |
| PANK2 | Pantothenate kinase 2, mitochondrial | Mitochondrial isoform that catalyzes the phosphorylation of pantothenate to generate 4’-phosphopantothenate in the first and rate-determining step of coenzyme A (CoA) synthesis. |
| RP1L1 | Retinitis pigmentosa 1-like 1 protein | Required for the differentiation of photoreceptor cells. |
| PNPLA6 | Patatin-like phospholipase domain-containing protein 6 | Phospholipase B that deacylates intracellular phosphatidylcholine (PtdCho), generating glycerophosphocholine (GroPtdCho). |
| USH1G | pre-mRNA splicing regulator USH1G | Plays a role in pre-mRNA splicing by regulating the release and transfer of U4/U6.U5 tri-small nuclear ribonucleoprotein (tri-snRNP) complexes from their assembly site in Cajal bodies to nuclear speckles, thereby contributing to the assemb… |
| WHRN | Whirlin | Involved in hearing and vision as member of the USH2 complex. |
| DNAJC30 | DnaJ homolog subfamily C member 30, mitochondrial | Mitochondrial protein enriched in neurons that acts as a regulator of mitochondrial respiration. |
| TUBGCP4 | Gamma-tubulin complex component 4 | Component of the gamma-tubulin ring complex (gTuRC) which mediates microtubule nucleation. |
| ZNF423 | Zinc finger protein 423 | Transcription factor that can both act as an activator or a repressor depending on the context. |
| MFN2 | Mitofusin-2 | Mitochondrial outer membrane GTPase that mediates mitochondrial clustering and fusion. |
| ARHGEF18 | Rho guanine nucleotide exchange factor 18 | Acts as a guanine nucleotide exchange factor (GEF) for RhoA GTPases. |
Protein-family classification
Druggable: 20 · Difficult: 14 · Unknown: 41 · Druggable fraction: 0.27
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Ion channel | 4 | 6.0× | 0.042 |
| Scaffold/PPI | 9 | 2.1× | 0.129 |
| Protease | 3 | 1.5× | 0.757 |
| Enzyme (other) | 8 | 1.3× | 0.757 |
| Other/Unknown | 41 | 1.0× | 0.939 |
| GPCR | 3 | 1.0× | 0.939 |
| Transcription factor | 5 | 0.6× | 0.958 |
| Antibody/Immunoglobulin | 1 | 0.4× | 0.958 |
| Kinase | 1 | 0.4× | 0.958 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| MED12 | Other/Unknown | no | Mediator_Med12, Mediator_Med12_catenin-bd, Mediator_Med12_LCEWAV | |
| TMEM126A | Other/Unknown | no | TMEM126 | |
| OPA1 | Enzyme (other) | yes | 3.6.5.5 | Dynamin_GTPase, Dynamin, P-loop_NTPase |
| NDUFA7 | Other/Unknown | no | NDUA7 | |
| RGS9 | Other/Unknown | no | DEP_dom, G-protein_gamma-like_dom, RGS | |
| RHO | GPCR | yes | GPCR_Rhodpsn, Rhodopsin, Opsin | |
| RLBP1 | Other/Unknown | no | CRAL-TRIO_dom, CRAL/TRIO_N_dom, CRAL/TRIO_N_dom_sf | |
| ROM1 | Other/Unknown | no | Peripherin/rom-1, Tetraspanin_EC2_sf, Peripherin/rom-1_CS | |
| RP9 | Other/Unknown | no | PAP-1 | |
| RPGR | Other/Unknown | no | Reg_chr_condens, RCC1/BLIP-II, Signaling_Regulatory_Domain | |
| CWC27 | Enzyme (other) | yes | 5.2.1.8 | Cyclophilin-type_PPIase_dom, Cyclophilin-type_PPIase_CS, Cyclophilin-like_dom_sf |
| SEMA4A | Scaffold/PPI | no | Semap_dom, Plexin_repeat, WD40/YVTN_repeat-like_dom_sf | |
| SEMA6B | Scaffold/PPI | no | Semap_dom, Plexin_repeat, WD40/YVTN_repeat-like_dom_sf | |
| SLC24A1 | Other/Unknown | no | K/Na/Ca-exchanger, SLC24A1, NaCa_Exmemb | |
| SNAP25 | Other/Unknown | no | T_SNARE_dom, SNAP-25_dom, SNAP-25_N_SNARE_chord | |
| SPG7 | Protease | yes | 3.4.24.B18 | Peptidase_M41, AAA+_ATPase, ATPase_AAA_core |
| SSBP1 | Other/Unknown | no | Primosome_PriB/ssb, ssDNA-bd, NA-bd_OB-fold | |
| PLK4 | Kinase | yes | 2.7.11.21 | Prot_kinase_dom, POLO_box_dom, Tyr_kinase_AS |
| ACO2 | Enzyme (other) | yes | 4.2.1.3 | AconitaseA/IPMdHydase_ssu_swvl, Acoase/IPM_deHydtase_lsu_aba, Aconitase_mito-like |
| TTPA | Other/Unknown | no | CRAL-TRIO_dom, CRAL/TRIO_N_dom, CRAL/TRIO_N_dom_sf | |
| USH1C | Scaffold/PPI | no | PDZ, Harmonin_N, PDZ_sf | |
| USH2A | Antibody/Immunoglobulin | yes | Laminin_G, LE_dom, FN3_dom | |
| CLRN1 | Other/Unknown | no | Clarin | |
| WFS1 | Other/Unknown | no | TPR-like_helical_dom_sf, Wolframin, Wolframin_fam | |
| SCAPER | Transcription factor | no | Matrin/U1-like-C_Znf_C2H2, Znf_C2H2_type, SCAPER_N | |
| ARL6 | Other/Unknown | no | Small_GTP-bd, Small_GTPase_ARF/SAR, Small_GTPase_ARF | |
| ESPN | Scaffold/PPI | no | Ankyrin_rpt, WH2_dom, Ankyrin_rpt-contain_sf | |
| RPGRIP1 | Other/Unknown | no | C2_dom, C2-C2_1, RPGRIP1_fam | |
| ABITRAM | Other/Unknown | no | Single_hybrid_motif, GCV_H/Fam206, Abitram | |
| CDH23 | Other/Unknown | no | Cadherin-like_dom, Cadherin-like_sf, Cadherin_CS | |
| ADGRA3 | GPCR | yes | GPS, Cys-rich_flank_reg_C, GPCR_2_secretin-like | |
| CABP4 | Other/Unknown | no | EF_hand_dom, EF-hand-dom_pair, EF_Hand_1_Ca_BS | |
| CACNA1F | Ion channel | yes | VDCCAlpha1, VDCC_L_a1su, Ion_trans_dom | |
| PIGQ | Enzyme (other) | yes | 2.4.1.198 | PigQ/GPI1 |
| C1QTNF5 | Other/Unknown | no | C1q_dom, Collagen, Tumour_necrosis_fac-like_dom | |
| ELOVL1 | Other/Unknown | no | ELO_fam, ELO_CS, ELOVL1 | |
| CDHR1 | Other/Unknown | no | Cadherin-like_dom, Cadherin-like_sf, Cadherin_CS | |
| PCDH15 | Other/Unknown | no | Cadherin-like_dom, Cadherin-like_sf, Cadherin_CS | |
| GPHN | Other/Unknown | no | MoaB/Mog_dom, MoeA_linker/N, MoeA_C_domain_IV | |
| NBAS | Scaffold/PPI | no | Quino_amine_DH_bsu, Sec39_domain, WD40/YVTN_repeat-like_dom_sf | |
| ABHD12 | Other/Unknown | no | AB_hydrolase_1, AB_hydrolase_fold | |
| PANK2 | Enzyme (other) | yes | 2.7.1.33 | Type_II_PanK, ATPase_NBD |
| RP1L1 | Other/Unknown | no | Doublecortin_dom, Doublecortin_dom_sf | |
| PNPLA6 | Other/Unknown | no | cNMP-bd_dom, LysoPLipase_patatin_CS, PNPLA_dom | |
| USH1G | Scaffold/PPI | no | SAM, Ankyrin_rpt, SAM/pointed_sf | |
| WHRN | Scaffold/PPI | no | PDZ, Whirlin_HN-like_dom2, PDZ_sf | |
| DNAJC30 | Other/Unknown | no | DnaJ_domain, J_dom_sf, Mito_ATP_Synthase-Asso | |
| TUBGCP4 | Other/Unknown | no | GCP, GCP_C, GCP_N | |
| ZNF423 | Transcription factor | no | Znf_C2H2_type, Znf_C2H2_sf | |
| MFN2 | Other/Unknown | no | Fzo/mitofusin_HR2, Mitofusin_fam, P-loop_NTPase |
Expression context
Cohort genes with no expression data: 0.
64 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 75 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| endothelial cell | 7 |
| apex of heart | 7 |
| primordial germ cell in gonad | 7 |
| right uterine tube | 7 |
| calcaneal tendon | 6 |
| male germ line stem cell (sensu Vertebrata) in testis | 6 |
| ventricular zone | 6 |
| adrenal tissue | 5 |
| C1 segment of cervical spinal cord | 5 |
| sperm | 5 |
| sural nerve | 5 |
| right lobe of liver | 5 |
| secondary oocyte | 5 |
| right adrenal gland | 4 |
| right adrenal gland cortex | 4 |
| left ventricle myocardium | 4 |
| oocyte | 4 |
| bronchial epithelial cell | 4 |
| left testis | 4 |
| right testis | 4 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| MED12 | 281 | ubiquitous | marker | right adrenal gland cortex, right adrenal gland, left ovary |
| TMEM126A | 257 | ubiquitous | marker | left ventricle myocardium, tibialis anterior, deltoid |
| OPA1 | 288 | ubiquitous | marker | adrenal tissue, calcaneal tendon, endothelial cell |
| NDUFA7 | 164 | ubiquitous | marker | hindlimb stylopod muscle, apex of heart, gastrocnemius |
| RGS9 | 178 | ubiquitous | marker | putamen, caudate nucleus, islet of Langerhans |
| RHO | 38 | tissue_specific | marker | optic choroid, neuron projection bundle connecting eye with brain, diaphragm |
| RLBP1 | 126 | tissue_specific | marker | pigmented layer of retina, retina, optic choroid |
| ROM1 | 201 | broad | marker | primordial germ cell in gonad, C1 segment of cervical spinal cord, spinal cord |
| RP9 | 256 | ubiquitous | marker | oocyte, left ventricle myocardium, hindlimb stylopod muscle |
| RPGR | 281 | ubiquitous | marker | sperm, bronchial epithelial cell, right uterine tube |
| CWC27 | 253 | ubiquitous | marker | tendon of biceps brachii, medial globus pallidus, globus pallidus |
| SEMA4A | 219 | broad | marker | monocyte, mononuclear cell, leukocyte |
| SEMA6B | 177 | ubiquitous | marker | right frontal lobe, anterior cingulate cortex, cingulate cortex |
| SLC24A1 | 220 | ubiquitous | marker | endothelial cell, sural nerve, male germ line stem cell (sensu Vertebrata) in testis |
| SNAP25 | 220 | broad | marker | pons, cerebellar cortex, cerebellum |
| SPG7 | 302 | ubiquitous | marker | primordial germ cell in gonad, sural nerve, left lobe of thyroid gland |
| SSBP1 | 153 | ubiquitous | marker | calcaneal tendon, endometrium, islet of Langerhans |
| PLK4 | 201 | ubiquitous | marker | ventricular zone, ganglionic eminence, primordial germ cell in gonad |
| ACO2 | 291 | ubiquitous | marker | heart right ventricle, apex of heart, left ventricle myocardium |
| TTPA | 135 | broad | yes | right lobe of liver, liver, buccal mucosa cell |
| USH1C | 203 | broad | marker | mucosa of transverse colon, C1 segment of cervical spinal cord, rectum |
| USH2A | 30 | tissue_specific | marker | male germ line stem cell (sensu Vertebrata) in testis, right lobe of liver, buccal mucosa cell |
| CLRN1 | 61 | tissue_specific | marker | adrenal tissue, right adrenal gland cortex, right adrenal gland |
| WFS1 | 280 | ubiquitous | marker | right ovary, left ovary, body of uterus |
| SCAPER | 282 | ubiquitous | marker | cortical plate, male germ line stem cell (sensu Vertebrata) in testis, sural nerve |
| ARL6 | 228 | ubiquitous | marker | oviduct epithelium, Brodmann (1909) area 23, endothelial cell |
| ESPN | 184 | broad | marker | right testis, left testis, right uterine tube |
| RPGRIP1 | 168 | tissue_specific | marker | left testis, sperm, right testis |
| ABITRAM | 287 | ubiquitous | marker | bronchial epithelial cell, tongue squamous epithelium, epithelium of bronchus |
| CDH23 | 161 | broad | marker | ventricular zone, left ovary, right ovary |
Protein interactions among cohort
Intra-cohort edges: 82.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| ACO2 | 4,776 |
| SSBP1 | 4,725 |
| SPG7 | 3,970 |
| MFN2 | 3,853 |
| PLK4 | 3,694 |
| PMPCA | 3,679 |
| RHO | 3,578 |
| WFS1 | 3,409 |
| MED12 | 3,322 |
| CWC27 | 2,984 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| ABHD12 | ZNF408 | string_interaction |
| ACO2 | DNAJC30 | intact |
| ACO2 | ISCA2 | string_interaction |
| ADGRA3 | ADGRV1 | string_interaction |
| ADGRV1 | CDH23 | string_interaction |
| ADGRV1 | CLRN1 | string_interaction |
| ADGRV1 | PCDH15 | string_interaction |
| ADGRV1 | USH1G | string_interaction |
| ADGRV1 | USH2A | string_interaction |
| ADGRV1 | WHRN | string_interaction |
| ARL6 | BBS7 | intact, string_interaction |
| BBS7 | INPP5E | string_interaction |
| C10orf105 | CDH23 | string_interaction |
| CABP4 | CACNA1F | biogrid_interaction, string_interaction |
| CABP4 | CACNA2D4 | string_interaction |
| CABP4 | SLC24A1 | string_interaction |
| CACNA1F | CACNA2D4 | string_interaction |
| CACNA1F | RPGR | string_interaction |
| CACNA2D4 | KCNV2 | string_interaction |
| CDH23 | CLRN1 | string_interaction |
| CDH23 | ESPN | string_interaction |
| CDH23 | PCDH15 | string_interaction |
| CDH23 | USH1C | biogrid_interaction, intact |
| CDH23 | USH1G | string_interaction |
| CDH23 | USH2A | string_interaction |
| CDH23 | WHRN | string_interaction |
| CDHR1 | KCNV2 | string_interaction |
| CDHR1 | RPGRIP1 | string_interaction |
| CDHR1 | SEMA4A | string_interaction |
| CEP250 | CLRN1 | string_interaction |
| CEP250 | USH1G | string_interaction |
| CLRN1 | PCDH15 | string_interaction |
| CLRN1 | USH1G | string_interaction |
| CLRN1 | USH2A | string_interaction |
| CLRN1 | WHRN | string_interaction |
| CNGA1 | RHO | string_interaction |
| CNGA1 | ROM1 | string_interaction |
| CNGA1 | SLC24A1 | biogrid_interaction, string_interaction |
| CNGA3 | KCNV2 | string_interaction |
| CNGA3 | RHO | string_interaction |
| CNGA3 | RPGR | string_interaction |
| CNGA3 | SLC24A1 | string_interaction |
| DNAJC30 | NDUFA7 | biogrid_interaction, intact |
| ESPN | WHRN | string_interaction |
| INPP5E | RPGR | intact |
| INVS | NPHP4 | biogrid_interaction, intact, string_interaction |
| KCNV2 | RPGRIP1 | string_interaction |
| MFN2 | OPA1 | string_interaction |
| NBAS | SCAPER | string_interaction |
| NDUFA7 | TTPA | intact |
Structural data
PDB: 39 · AlphaFold-only: 36 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| TUBGCP6 | Q96RT7 | 30 |
| TUBGCP4 | Q9UGJ1 | 28 |
| PLK4 | O00444 | 19 |
| CNGA1 | P29973 | 19 |
| SNAP25 | P60880 | 14 |
| OPA1 | O60313 | 11 |
| USH1C | Q9Y6N9 | 11 |
| POMGNT1 | Q8WZA1 | 10 |
| CNGA3 | Q16281 | 10 |
| CWC27 | Q6UX04 | 9 |
| PCDH15 | Q96QU1 | 8 |
| NDUFA7 | O95182 | 7 |
| TTPA | P49638 | 6 |
| CDH23 | Q9H251 | 6 |
| SSBP1 | Q04837 | 5 |
| WHRN | Q9P202 | 5 |
| RHO | P08100 | 4 |
| RLBP1 | P12271 | 4 |
| WDR19 | Q8NEZ3 | 4 |
| MECR | Q9BV79 | 4 |
| MED12 | Q93074 | 3 |
| RPGR | Q92834 | 3 |
| USH1G | Q495M9 | 3 |
| MFN2 | O95140 | 3 |
| TRNT1 | Q96Q11 | 3 |
| SCAPER | Q9BY12 | 2 |
| C1QTNF5 | Q9BXJ0 | 2 |
| ROM1 | Q03395 | 1 |
| SPG7 | Q9UQ90 | 1 |
| ARL6 | Q9H0F7 | 1 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| ACO2 | Q99798 | 95.44 |
| BBS7 | Q8IWZ6 | 92.99 |
| CLRN1 | P58418 | 90.74 |
| ELOVL1 | Q9BW60 | 90.46 |
| TMEM126A | Q9H061 | 89.75 |
| PMPCA | Q10713 | 88.46 |
| ABHD12 | Q8N2K0 | 85.60 |
| SEMA4A | Q9H3S1 | 85.05 |
| CACNA2D4 | Q7Z3S7 | 81.69 |
| IFT74 | Q96LB3 | 81.21 |
| ABITRAM | Q9NX38 | 80.21 |
| RP9 | Q8TA86 | 78.99 |
| CDHR1 | Q96JP9 | 78.79 |
| ISCA2 | Q86U28 | 77.98 |
| KCNV2 | Q8TDN2 | 75.55 |
| SEMA6B | Q9H3T3 | 74.81 |
| NBAS | A2RRP1 | 74.42 |
| RGS9 | O75916 | 74.35 |
| WFS1 | O76024 | 73.85 |
| NPHP4 | O75161 | 72.44 |
| INVS | Q9Y283 | 70.76 |
| ADGRA3 | Q8IWK6 | 70.20 |
| PNPLA6 | Q8IY17 | 69.75 |
| ESPN | B1AK53 | 68.76 |
| CACNA1F | O60840 | 67.46 |
| USP45 | Q70EL2 | 66.28 |
| CABP4 | P57796 | 65.01 |
| PIGQ | Q9BRB3 | 64.70 |
| C10orf105 | Q8TEF2 | 63.46 |
| ARHGEF18 | Q6ZSZ5 | 62.10 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 306. Enrichment computed across 164 evidence-associated genes (114 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 114 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Cilium Assembly | 12 | 11.4× | 1e-07 | ARL6, BBS7, INPP5E, AHI1, CEP78, BBS10, SCLT1, CEP290 (+4 more) |
| Anchoring of the basal body to the plasma membrane | 11 | 10.9× | 7e-07 | PLK4, CEP250, NPHP4, AHI1, CEP78, SCLT1, CEP290, RPGRIP1L (+3 more) |
| Organelle biogenesis and maintenance | 13 | 7.5× | 2e-06 | SSBP1, ARL6, BBS7, INPP5E, AHI1, CEP78, BBS10, SCLT1 (+5 more) |
| The canonical retinoid cycle in rods (twilight vision) | 6 | 27.3× | 4e-06 | RHO, RLBP1, CYP4V2, ABCA4, MYO7A, RBP3 |
| Sensory processing of sound by inner hair cells of the cochlea | 8 | 11.4× | 3e-05 | SNAP25, USH1C, ESPN, CDH23, PCDH15, USH1G, WHRN, MYO7A |
| Mitochondrial protein degradation | 9 | 9.0× | 3e-05 | OPA1, SPG7, SSBP1, ACO2, PMPCA, AFG3L2, MT-CO1, MT-ND1 (+1 more) |
| Sensory processing of sound by outer hair cells of the cochlea | 7 | 12.5× | 6e-05 | USH1C, ESPN, CDH23, PCDH15, USH1G, WHRN, MYO7A |
| Activation of the phototransduction cascade | 4 | 33.4× | 2e-04 | RHO, SLC24A1, CNGA1, CNGB1 |
| Intraflagellar transport | 6 | 10.5× | 6e-04 | WDR19, IFT74, IFT140, DYNC2H1, IFT172, KIF3B |
| Recruitment of mitotic centrosome proteins and complexes | 7 | 8.3× | 6e-04 | PLK4, TUBGCP4, TUBGCP6, CEP250, CEP78, CEP290, ALMS1 |
| Inactivation, recovery and regulation of the phototransduction cascade | 5 | 13.9× | 7e-04 | RGS9, RHO, CNGA1, CNGB1, GUCY2D |
| Hedgehog ‘off’ state | 6 | 9.4× | 0.001 | WDR19, IFT140, RPGRIP1L, DYNC2H1, IFT172, MKS1 |
| Recruitment of NuMA to mitotic centrosomes | 7 | 7.2× | 0.001 | PLK4, TUBGCP4, TUBGCP6, CEP250, CEP78, CEP290, ALMS1 |
| Complex I biogenesis | 6 | 8.7× | 0.001 | TMEM126A, MT-ND1, MT-ND4, MT-ND6, NDUFA7, NDUFS2 |
| BBSome-mediated cargo-targeting to cilium | 4 | 17.4× | 0.001 | ARL6, BBS7, BBS10, BBS9 |
| Respiratory electron transport | 7 | 5.8× | 0.004 | TMEM126A, MT-CO1, MT-ND1, MT-ND4, MT-ND6, NDUFA7, NDUFS2 |
| Processing of SMDT1 | 3 | 16.7× | 0.012 | SPG7, PMPCA, AFG3L2 |
| Loss of Nlp from mitotic centrosomes | 5 | 7.0× | 0.012 | PLK4, CEP250, CEP78, CEP290, ALMS1 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 5 | 7.0× | 0.012 | PLK4, CEP250, CEP78, CEP290, ALMS1 |
| AURKA Activation by TPX2 | 5 | 6.7× | 0.014 | PLK4, CEP250, CEP78, CEP290, ALMS1 |
| Mitochondrial calcium ion transport | 3 | 14.3× | 0.016 | SPG7, PMPCA, AFG3L2 |
| Cargo trafficking to the periciliary membrane | 4 | 8.7× | 0.016 | ARL6, BBS7, INPP5E, BBS10 |
| The retinoid cycle in cones (daylight vision) | 2 | 28.6× | 0.026 | RLBP1, RBP3 |
| Regulation of PLK1 Activity at G2/M Transition | 5 | 5.6× | 0.026 | PLK4, CEP250, CEP78, CEP290, ALMS1 |
| Citric acid cycle (TCA cycle) | 3 | 11.1× | 0.029 | ACO2, ISCA2, IDH3B |
| Opsins | 2 | 22.3× | 0.038 | RHO, RGR |
| Signaling by RNF43 mutants | 2 | 22.3× | 0.038 | FZD4, LRP5 |
| Sensory processing of sound | 3 | 8.1× | 0.064 | SNAP25, CDH23, MYO7A |
| Sensory Perception | 5 | 4.2× | 0.073 | SLC24A1, SNAP25, CDH23, ABCA4, MYO7A |
| Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D) | 1 | 100.2× | 0.082 | SLC24A1 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 161 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| visual perception | 44 | 21.7× | 4e-44 | OPA1, RGS9, RHO, RLBP1, ROM1, RPGR, SLC24A1, USH2A (+36 more) |
| photoreceptor cell maintenance | 20 | 44.5× | 4e-26 | RHO, USH1C, USH2A, CLRN1, CDH23, CDHR1, PCDH15, RP1L1 (+12 more) |
| photoreceptor cell outer segment organization | 11 | 72.0× | 5e-17 | ROM1, CDHR1, RP1L1, NPHP4, CNGB1, AHI1, TOPORS, CRB1 (+3 more) |
| sensory perception of light stimulus | 9 | 104.7× | 1e-16 | USH1C, USH2A, CLRN1, CDH23, PCDH15, USH1G, WHRN, ADGRV1 (+1 more) |
| cilium assembly | 21 | 9.6× | 9e-13 | RPGR, PLK4, ARL6, WDR19, CEP250, BBS7, IFT74, INPP5E (+13 more) |
| non-motile cilium assembly | 13 | 23.5× | 1e-12 | RPGRIP1, CEP250, BBS7, IFT74, BBS10, CEP290, IFT140, RPGRIP1L (+5 more) |
| detection of light stimulus involved in visual perception | 10 | 40.3× | 3e-12 | ROM1, CACNA1F, CEP250, CACNA2D4, CNGB1, EYS, CRB1, REEP6 (+2 more) |
| equilibrioception | 6 | 89.7× | 5e-10 | USH1C, CLRN1, CDH23, PCDH15, USH1G, MYO7A |
| retina development in camera-type eye | 11 | 17.4× | 3e-09 | SCAPER, RP1L1, NPHP4, TTLL5, CNGA3, ZNF513, MFSD8, GRM6 (+3 more) |
| determination of left/right symmetry | 10 | 15.9× | 6e-08 | ARL6, BBS7, IFT74, IFT140, RPGRIP1L, CC2D2A, DYNC2H1, KIF3B (+2 more) |
| sensory perception of sound | 14 | 8.8× | 6e-08 | USH1C, USH2A, CLRN1, WFS1, ESPN, CDH23, PCDH15, USH1G (+6 more) |
| aerobic respiration | 8 | 12.3× | 2e-05 | PANK2, MFN2, MT-CO1, MT-ND1, MT-ND4, MT-ND6, NDUFA7, NDUFS2 |
| eye photoreceptor cell development | 5 | 26.2× | 7e-05 | RPGR, POC5, CEP290, MYO7A, NR2E3 |
| inner ear receptor cell stereocilium organization | 5 | 26.2× | 7e-05 | USH1C, USH1G, WHRN, ADGRV1, MKS1 |
| mitochondrial respiratory chain complex I assembly | 6 | 15.3× | 1e-04 | TMEM126A, MIEF1, MT-ND1, MT-ND4, MT-ND6, NDUFS2 |
| protein localization to cilium | 6 | 14.9× | 2e-04 | ARL6, ZNF423, CEP78, IFT140, DYNC2H1, BBS9 |
| retina layer formation | 5 | 20.1× | 2e-04 | ARL6, TSPAN12, TOPORS, CRB1, PROM1 |
| regulation of smoothened signaling pathway | 5 | 19.4× | 2e-04 | ARL6, IFT140, RPGRIP1L, MKS1, OTX2 |
| monoatomic cation transmembrane transport | 5 | 19.4× | 2e-04 | CNGA1, CNGA3, CNGB1, CNGB3, TRPM1 |
| maintenance of animal organ identity | 3 | 62.8× | 3e-04 | USH2A, ADGRV1, NPHP3 |
| inner ear receptor cell differentiation | 3 | 62.8× | 3e-04 | USH2A, WHRN, ADGRV1 |
| Norrin signaling pathway | 3 | 62.8× | 3e-04 | TSPAN12, FZD4, LRP5 |
| intraciliary transport | 5 | 17.4× | 3e-04 | RPGR, WDPCP, IFT172, LCA5, KIF3B |
| cellular response to light stimulus | 4 | 26.2× | 5e-04 | RHO, CRB1, TRPM1, RGR |
| phototransduction | 5 | 15.4× | 6e-04 | RHO, CABP4, CNGB1, NR2E3, RGR |
| kidney development | 8 | 7.0× | 7e-04 | WFS1, INVS, WDPCP, CEP290, RPGRIP1L, CC2D2A, DYNC2H1, NPHP3 |
| retinal blood vessel morphogenesis | 3 | 44.9× | 9e-04 | FZD4, LAMA1, LRP5 |
| protein localization to photoreceptor outer segment | 3 | 44.9× | 9e-04 | ROM1, SPATA7, PCARE |
| establishment of protein localization | 5 | 13.4× | 0.001 | USH2A, GPHN, WHRN, ADGRV1, WDPCP |
| auditory receptor cell stereocilium organization | 4 | 20.9× | 0.001 | CLRN1, CDH23, WHRN, MYO7A |
Therapeutics
Drug target analysis
Approved (phase 4): 5 · Phase ≥3: 5 · Phased (≥1): 7 · Undrugged: 68
Druggability breadth: 53 of 164 evidence-associated genes (32%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Genes with an approved drug
The molecule shown is one approved compound that hits the gene — not necessarily a drug of choice or one indicated for this disease.
| Symbol | Example approved molecule |
|---|---|
| OPA1 | MOMELOTINIB |
| PLK4 | MOMELOTINIB |
| CACNA1F | BEPRIDIL |
| ABHD12 | ORLISTAT |
| CACNA2D4 | NIMODIPINE |
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| PLK4 | 65 | 4 |
| CACNA1F | 48 | 4 |
| OPA1 | 2 | 4 |
| ABHD12 | 2 | 4 |
| CACNA2D4 | 2 | 4 |
| MED12 | 1 | 2 |
| CWC27 | 1 | 2 |
| TMEM126A | 0 | 0 |
| NDUFA7 | 0 | 0 |
| RGS9 | 0 | 0 |
Drugs targeting cohort genes (top 30)
| Molecule | Max phase | Targets in cohort |
|---|---|---|
| MOMELOTINIB | 4 | OPA1, PLK4 |
| FEDRATINIB | 4 | PLK4 |
| AXITINIB | 4 | PLK4 |
| SORAFENIB | 4 | PLK4 |
| RUXOLITINIB | 4 | PLK4 |
| ENTRECTINIB | 4 | PLK4 |
| DABRAFENIB | 4 | PLK4 |
| FOSTAMATINIB | 4 | PLK4 |
| CERITINIB | 4 | PLK4 |
| VANDETANIB | 4 | PLK4 |
| GILTERITINIB | 4 | PLK4 |
| PAZOPANIB | 4 | PLK4 |
| NINTEDANIB | 4 | PLK4 |
| SUNITINIB | 4 | CACNA1F, PLK4 |
| DASATINIB | 4 | CACNA1F, PLK4 |
| ERLOTINIB | 4 | PLK4 |
| CRIZOTINIB | 4 | PLK4 |
| MIDOSTAURIN | 4 | PLK4 |
| IMATINIB | 4 | PLK4 |
| BEPRIDIL | 4 | CACNA1F |
| IMIPRAMINE | 4 | CACNA1F |
| HALOFANTRINE | 4 | CACNA1F |
| DROPERIDOL | 4 | CACNA1F |
| SAQUINAVIR | 4 | CACNA1F |
| DULOXETINE | 4 | CACNA1F |
| DIAZEPAM | 4 | CACNA1F |
| SERTINDOLE | 4 | CACNA1F |
| QUINIDINE | 4 | CACNA1F |
| LAMIVUDINE | 4 | CACNA1F |
| PIMOZIDE | 4 | CACNA1F |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 11.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| PLK4 | 303 | Binding:293, Functional:10 |
| CACNA1F | 221 | Binding:135, Functional:79, Toxicity:5, ADMET:2 |
| ABHD12 | 35 | Binding:31, Toxicity:3, ADMET:1 |
| ELOVL1 | 22 | Binding:22 |
| KCNV2 | 21 | Binding:20, Toxicity:1 |
| CACNA2D4 | 13 | Binding:13 |
| PCDH15 | 9 | Binding:9 |
| CWC27 | 7 | Binding:7 |
| MED12 | 6 | Binding:6 |
| TTPA | 5 | Binding:5 |
| NDUFA7 | 4 | Binding:4 |
| MFN2 | 3 | Binding:3 |
| USP45 | 3 | Binding:3 |
| OPA1 | 2 | Binding:2 |
| ADGRA3 | 2 | Binding:2 |
| TMEM126A | 1 | Binding:1 |
| RHO | 1 | Binding:1 |
| SSBP1 | 1 | Binding:1 |
| WFS1 | 1 | Binding:1 |
| NBAS | 1 | Binding:1 |
| PANK2 | 1 | Binding:1 |
| PNPLA6 | 1 | Binding:1 |
| TUBGCP4 | 1 | Binding:1 |
| PMPCA | 1 | Binding:1 |
| POMGNT1 | 1 | Binding:1 |
Cohort enzymes (BRENDA EC)
| Symbol | EC numbers | Names |
|---|---|---|
| OPA1 | 3.6.5.5 | dynamin GTPase |
| CWC27 | 5.2.1.8 | peptidylprolyl isomerase |
| SPG7 | 3.4.24.B18 | |
| PLK4 | 2.7.11.21 | polo kinase |
| ACO2 | 4.2.1.3 | aconitate hydratase |
| PIGQ | 2.4.1.198 | phosphatidylinositol N-acetylglucosaminyltransferase |
| PANK2 | 2.7.1.33 | pantothenate kinase |
| TRNT1 | 2.7.7.72 | CCA tRNA nucleotidyltransferase |
| PMPCA | 3.4.24.64 | mitochondrial processing peptidase |
| POMGNT1 | 2.4.1.312 | protein O-mannose beta-1,4-N-acetylglucosaminyltransferase |
| INPP5E | 3.1.3.36 | phosphoinositide 5-phosphatase |
Cohort genes with high screening signal
≥100 ChEMBL assays — a studied-ness signal; see Therapeutics for approved-drug status.
| Symbol | ChEMBL assays |
|---|---|
| PLK4 | 303 |
| CACNA1F | 221 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 75; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
30 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
| Compound | Max phase | Cohort target (bioactivity) |
|---|---|---|
| MOMELOTINIB | 4 | OPA1, PLK4 |
| FEDRATINIB | 4 | PLK4 |
| AXITINIB | 4 | PLK4 |
| SORAFENIB | 4 | PLK4 |
| RUXOLITINIB | 4 | PLK4 |
| ENTRECTINIB | 4 | PLK4 |
| DABRAFENIB | 4 | PLK4 |
| FOSTAMATINIB | 4 | PLK4 |
| CERITINIB | 4 | PLK4 |
| VANDETANIB | 4 | PLK4 |
| GILTERITINIB | 4 | PLK4 |
| PAZOPANIB | 4 | PLK4 |
| NINTEDANIB | 4 | PLK4 |
| SUNITINIB | 4 | CACNA1F, PLK4 |
| DASATINIB | 4 | CACNA1F, PLK4 |
| ERLOTINIB | 4 | PLK4 |
| CRIZOTINIB | 4 | PLK4 |
| MIDOSTAURIN | 4 | PLK4 |
| IMATINIB | 4 | PLK4 |
| BEPRIDIL | 4 | CACNA1F |
| IMIPRAMINE | 4 | CACNA1F |
| HALOFANTRINE | 4 | CACNA1F |
| DROPERIDOL | 4 | CACNA1F |
| SAQUINAVIR | 4 | CACNA1F |
| DULOXETINE | 4 | CACNA1F |
| DIAZEPAM | 4 | CACNA1F |
| SERTINDOLE | 4 | CACNA1F |
| QUINIDINE | 4 | CACNA1F |
| LAMIVUDINE | 4 | CACNA1F |
| PIMOZIDE | 4 | CACNA1F |
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 5 | OPA1, PLK4, CACNA1F, ABHD12, CACNA2D4 |
| B | Phased (≥1) drug, not yet approved | 2 | MED12, CWC27 |
| C | Druggable family + PDB, no drug | 8 | RHO, SPG7, PANK2, TRNT1, POMGNT1, INPP5E, CNGA1, CNGA3 |
| D | Druggable family + AlphaFold only, no drug | 8 | ACO2, USH2A, ADGRA3, PIGQ, ADGRV1, PMPCA, KCNV2, USP45 |
| E | Difficult family or no structure, no drug | 52 | TMEM126A, NDUFA7, RGS9, RLBP1, ROM1, RP9, RPGR, SEMA4A, SEMA6B, SLC24A1 (+42 more) |
Undrugged target profiles
68 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| CABP4 | 0 | CACNA1F |
| TMEM126A | 1 | — |
| NDUFA7 | 4 | — |
| RGS9 | 0 | — |
| RHO | 1 | — |
| RLBP1 | 0 | — |
| ROM1 | 0 | — |
| RP9 | 0 | — |
| RPGR | 0 | — |
| SEMA4A | 0 | — |
| SEMA6B | 0 | — |
| SLC24A1 | 0 | — |
| SNAP25 | 0 | — |
| SPG7 | 0 | — |
| SSBP1 | 1 | — |
| ACO2 | 0 | — |
| TTPA | 5 | — |
| USH1C | 0 | — |
| USH2A | 0 | — |
| CLRN1 | 0 | — |
| WFS1 | 1 | — |
| SCAPER | 0 | — |
| ARL6 | 0 | — |
| ESPN | 0 | — |
| RPGRIP1 | 0 | — |
| ABITRAM | 0 | — |
| CDH23 | 0 | — |
| ADGRA3 | 2 | — |
| PIGQ | 0 | — |
| C1QTNF5 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 10.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 5 |
| PHASE1/PHASE2 | 2 |
| PHASE1 | 2 |
| PHASE2/PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02882477 | PHASE2/PHASE3 | UNKNOWN | Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy |
| NCT01834079 | PHASE1/PHASE2 | UNKNOWN | Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease |
| NCT04680143 | PHASE1/PHASE2 | COMPLETED | Systemic Erythropoietin Injection in Patients Having Optic Atrophy |
| NCT05147701 | PHASE1 | RECRUITING | Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION |
| NCT01064505 | PHASE1 | COMPLETED | Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients |
| NCT03011541 | Not specified | RECRUITING | Stem Cell Ophthalmology Treatment Study II |
| NCT04580979 | Not specified | COMPLETED | Natural History Study of FDXR Mutation-related Mitochondriopathy |
| NCT04594590 | Not specified | COMPLETED | Natural History Study of SLC25A46 Mutation-related Mitochondriopathy |
| NCT04723160 | Not specified | COMPLETED | Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph |
| NCT06390579 | Not specified | COMPLETED | Building Research With Artificial Intelligence in Neuro-Ophthalmology |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| DEFERIPRONE | 4 | 1 |
| SITAGLIPTIN | 4 | 1 |
Related Atlas pages
- Cohort genes: MED12, TMEM126A, OPA1, NDUFA7, RGS9, RHO, RLBP1, ROM1, RP9, RPGR, CWC27, SEMA4A, SEMA6B, SLC24A1, SNAP25, SPG7, SSBP1, PLK4, ACO2, TTPA, USH1C, USH2A, CLRN1, WFS1, SCAPER, ARL6, ESPN, RPGRIP1, ABITRAM, CDH23, ADGRA3, CABP4, CACNA1F, PIGQ, C1QTNF5, ELOVL1, CDHR1, PCDH15, GPHN, NBAS, ABHD12, PANK2, RP1L1, PNPLA6, USH1G, WHRN, DNAJC30, TUBGCP4, ZNF423, MFN2, ARHGEF18, TRNT1, ADGRV1, INVS, TUBGCP6, WDR19, CEP250, RTN4IP1, PMPCA, BBS7, NPHP4, POMGNT1, MECR, KCNV2, ISCA2, TTLL5, ZNF408, USP45, CACNA2D4, C10orf105, SPATA7, IFT74, INPP5E, CNGA1, CNGA3
- Drugs: Deferiprone, Sitagliptin